IL1B and myeloid sarcoma: These mechanisms also modulate neuroimmune responses by reducing the release of pro-inflammatory cytokines (such as TNF-α and IL-1β) from immune cells, and by influencing the activity of astrocytes and microglia, both of which are implicated in MS-related neuroinflammation [15,16,24,25].